Vishal Sah

Employment

• Centre for Cellular and Molecular Biology Research Scientist - II
  2024 - Present
• Centre for Cellular and Molecular Biology CSIR PhD
  2019 - 2025

Education

• Banaras Hindu University Bachelors in Science (Hons.)
  2014 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• MAVS Safeguards Mitochondrial Integrity to Drive a Potent Intrinsic Antiviral Program
  2025 DOI: 10.1101/2025.04.28.651145
  +Save
• SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells
  Microbiology Spectrum 2022 DOI: 10.1128/spectrum.01604-22
  +Save
• Equine immunoglobulin fragment F(ab’)2 displays high neutralizing capability against multiple SARS-CoV-2 variants
  Clinical Immunology 2022 DOI: 10.1016/j.clim.2022.108981
  +Save
• SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses
  2022 DOI: 10.1101/2022.02.22.481430
  +Save
• Retinoic Acid-Inducible Gene I-Like Receptors Activate Snail To Limit RNA Viral Infections
  Journal of Virology 2021 DOI: 10.1128/jvi.01216-21
  +Save
• SARS-CoV-2 Infection Causes Strong mTORC1 Inhibition and Massive Polysome Collapse
  2021 DOI: 10.1101/2021.05.08.443207
  +Save
• N440K variant of SARS-CoV-2 has Higher Infectious Fitness
  2021 DOI: 10.1101/2021.04.30.441434
  +Save
• Inactivation of SARS-CoV-2 by β-propiolactone Causes Aggregation of Viral Particles and Loss of Antigenic Potential
  2021 DOI: 10.1101/2021.04.22.441045
  +Save
• Development of Equine Immunoglobulin Fragment F(ab’)2with High Neutralizing Capability against SARS-CoV-2
  2021 DOI: 10.1101/2021.03.09.434030
  +Save